Cited by

• Pragmatic medicine in solid cancer: a translational alternative to precision medicine.

  Brábek J, Rosel D, Fernandes M. Brábek J, et al. Onco Targets Ther. 2016 Apr 5;9:1839-55. doi: 10.2147/OTT.S103832. eCollection 2016. Onco Targets Ther. 2016. PMID: 27103822 Free PMC article.
• Matching methods in precision oncology: An introduction and illustrative example.

  Weymann D, Laskin J, Jones SJM, Lim H, Renouf DJ, Roscoe R, Schrader KA, Sun S, Yip S, Marra MA, Regier DA. Weymann D, et al. Mol Genet Genomic Med. 2021 Jan;9(1):e1554. doi: 10.1002/mgg3.1554. Epub 2020 Nov 25. Mol Genet Genomic Med. 2021. PMID: 33237632 Free PMC article.
• Individualized therapy trials: navigating patient care, research goals and ethics.

  Kane PB, Bittlinger M, Kimmelman J. Kane PB, et al. Nat Med. 2021 Oct;27(10):1679-1686. doi: 10.1038/s41591-021-01519-y. Epub 2021 Oct 12. Nat Med. 2021. PMID: 34642487 Review.
• Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?

  Rossi E, Zamarchi R. Rossi E, et al. Front Genet. 2019 Oct 17;10:958. doi: 10.3389/fgene.2019.00958. eCollection 2019. Front Genet. 2019. PMID: 31681412 Free PMC article. Review.
• A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.

  Srivas R, Shen JP, Yang CC, Sun SM, Li J, Gross AM, Jensen J, Licon K, Bojorquez-Gomez A, Klepper K, Huang J, Pekin D, Xu JL, Yeerna H, Sivaganesh V, Kollenstart L, van Attikum H, Aza-Blanc P, Sobol RW, Ideker T. Srivas R, et al. Mol Cell. 2016 Aug 4;63(3):514-25. doi: 10.1016/j.molcel.2016.06.022. Epub 2016 Jul 21. Mol Cell. 2016. PMID: 27453043 Free PMC article.